scholarly article | Q13442814 |
P356 | DOI | 10.1093/CARCIN/BGI248 |
P698 | PubMed publication ID | 16251207 |
P50 | author | Barbara Wappenschmidt | Q63444312 |
Peter Bugert | Q96691995 | ||
Rüdiger Klaes | Q117235124 | ||
Rita Schmutzler | Q21264574 | ||
Barbara Burwinkel | Q28484015 | ||
Michael Untch | Q38292680 | ||
Alfons Meindl | Q63015490 | ||
Kari Hemminki | Q63213683 | ||
P2093 | author name string | Claus R Bartram | |
Bernd Frank | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 606-609 | |
P577 | publication date | 2005-10-26 | |
P1433 | published in | Carcinogenesis | Q326022 |
P1476 | title | Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. | |
P478 | volume | 27 |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q80195976 | A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers |
Q43721735 | An empirical comparison of meta-analyses of published gene-disease associations versus consortium analyses |
Q44712404 | Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy |
Q28392926 | Association of CASP9, CASP10 gene polymorphisms and tea drinking with colorectal cancer risk in the Han Chinese population |
Q34801008 | Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers |
Q36681986 | CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men. |
Q36615641 | CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population |
Q36981342 | Caspase polymorphisms and genetic susceptibility to multiple myeloma |
Q33614960 | Caspase polymorphisms and prognosis of hepatocellular carcinoma |
Q36335177 | Caspase-8 polymorphisms and risk of oral squamous cell carcinoma |
Q37860139 | Caspases and cancer |
Q33289658 | Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib |
Q35661406 | Fine-mapping CASP8 risk variants in breast cancer |
Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
Q88963822 | Genetic Modifiers of the Breast Tumor Microenvironment |
Q34118402 | Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma |
Q36331604 | Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q51050036 | Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India. |
Q53285164 | Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer. |
Q37096057 | Population differences in breast cancer severity |
Q35877750 | Prognostic Impact of Polymorphisms in the CASPASE Genes on Survival of Patients with Colorectal Cancer |
Q33636988 | The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck |
Search more.